Teva Pharmaceutical Industries Ltd. (TEVA)
39.60
-0.21
(-0.53%)
USD |
NYSE |
Sep 30, 16:00
39.60
0.00 (0.00%)
Pre-Market: 09:10
Teva Pharmaceutical Industries Price to Book Value : 5.950 for Sept. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 30, 2026 | 5.950 |
| September 29, 2026 | 5.982 |
| September 28, 2026 | 5.842 |
| September 25, 2026 | 5.889 |
| September 24, 2026 | 6.044 |
| September 23, 2026 | 5.862 |
| September 22, 2026 | 5.938 |
| September 21, 2026 | 6.020 |
| September 18, 2026 | 5.857 |
| September 17, 2026 | 5.889 |
| September 16, 2026 | 5.790 |
| September 15, 2026 | 5.898 |
| September 14, 2026 | 5.818 |
| September 11, 2026 | 5.560 |
| September 10, 2026 | 5.462 |
| September 09, 2026 | 5.537 |
| September 08, 2026 | 5.524 |
| September 04, 2026 | 5.464 |
| September 03, 2026 | 5.503 |
| September 02, 2026 | 5.634 |
| September 01, 2026 | 5.438 |
| August 31, 2026 | 5.417 |
| August 28, 2026 | 5.476 |
| August 27, 2026 | 5.653 |
| August 26, 2026 | 5.698 |
| Date | Value |
|---|---|
| August 25, 2026 | 5.725 |
| August 24, 2026 | 5.549 |
| August 21, 2026 | 5.611 |
| August 20, 2026 | 5.531 |
| August 19, 2026 | 5.630 |
| August 18, 2026 | 5.497 |
| August 17, 2026 | 5.479 |
| August 14, 2026 | 5.525 |
| August 13, 2026 | 5.488 |
| August 12, 2026 | 5.521 |
| August 11, 2026 | 5.482 |
| August 10, 2026 | 5.431 |
| August 07, 2026 | 5.313 |
| August 06, 2026 | 5.231 |
| August 05, 2026 | 5.217 |
| August 04, 2026 | 5.174 |
| August 03, 2026 | 5.178 |
| July 31, 2026 | 5.261 |
| July 30, 2026 | 5.321 |
| July 29, 2026 | 5.216 |
| July 28, 2026 | 4.759 |
| July 27, 2026 | 4.670 |
| July 24, 2026 | 4.630 |
| July 23, 2026 | 4.685 |
| July 22, 2026 | 4.530 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 32.16 |
| Bristol Myers Squibb Co. | 5.712 |
| RedHill Biopharma Ltd. | -- |
| Johnson & Johnson | 7.503 |
| Merck & Co., Inc. | 8.555 |
Price to Book Value Related Metrics
| PE Ratio | 66.59 |
| PS Ratio | 2.656 |
| Price to Free Cash Flow | 31.56 |
| Price | 39.60 |
| Earnings Yield | 1.50% |
| Market Cap | 46.13B |
| Operating PE Ratio | 14.13 |
| Normalized PE Ratio | 24.95 |